NVAX Stock Rises 7% in Pre-market as Novavax Starts Late-Stage Covid-19 Vaccine Trials in UK

2020-9-26 17:16

Coinspeaker NVAX Stock Rises 7% in Pre-market as Novavax Starts Late-Stage Covid-19 Vaccine Trials in UKFollowing the news about the progress with COVID-19 vaccine trials, Novavax shares which closed 0.

Similar to Notcoin - Blum - Airdrops In 2024

origin »

KuCoin Shares (KCS) на Currencies.ru

$ 0 (+0.00%)
Объем 24H $0
Изменеия 24h: 0.00 %, 7d: 0.00 %
Cегодня L: $0 - H: $9.9109
Капитализация $0 Rank 99999
Цена в час новости $ 0.9363 (-100%)

covid-19 vaccine novavax trials stock rises nvax

covid-19 vaccine → Результатов: 42


Pharmaceutical Giant AstraZeneca Resumes Clinical Trials for COVID-19 Vaccine, AZN Stock Slightly Up

Coinspeaker Pharmaceutical Giant AstraZeneca Resumes Clinical Trials for COVID-19 Vaccine, AZN Stock Slightly UpIn partnership with U. K. 's Oxford University, AstraZeneca said that it will resume the phase three clinical trial for its COVID-19 vaccine contender AZD1222 since it got an approval from UK's Medicines Health Regulatory Authority.

2020-9-13 12:56